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Background: Intercellular crosstalk and cellular plasticity are key factors in embry-
ogenesis and organogenesis. The microenvironment plays a critical role in directing
the progression of stem cells into differentiated cells. We hypothesized that inter-
cellular interaction between adult human mesenchymal stem cells and adult human
cardiomyocytes would induce stem cells to acquire the phenotypical characteristics
of cardiomyocytes, and we tested the role that direct cell-to-cell contact plays in
directing this differentiation process. Human mesenchymal stem cells were cultured
in the presence of human cardiomyocytes (“coculture”) or in the presence of media
conditioned by separate cultures of human cardiomyocytes (“conditioned media”).
Methods: Human cardiomyocytes were labeled with chloromethyl derivatives of
fluorescein diacetate. In the coculture experiments, human mesenchymal stem cells
and human cardiomyocytes were mixed at a 1:1 ratio in smooth muscle 2 media and
seeded at a cell density of 10,000 cells/cm2. Cells were cocultured in an incubator
at 37°C for 48 hours. Subsequently, fluorescence-activated cell sorting was used to
extract the differentiating human mesenchymal stem cells. In the conditioned media
experiments, human mesenchymal stem cells were incubated in media previously
conditioned by cardiomyocytes, in the presence and absence of serum (serum).
The conditioned media was changed 3 times, at intervals of 48 hours. Total RNA
was isolated and reverse transcriptase-polymerase chain reaction was performed for
expression of contractile proteins and cardiac specific genes. Immunostaining
against myosin heavy chain, -actin troponin-T, and troponin-I was performed.
Results: Fluorescence-activated cell sorting analysis identified 66% of the human
mesenchymal stem cells in the G1 phase. Differentiated hMSCs from the coculture
experiments expressed myosin heavy chain, -actin, and troponin-T by reverse
transcriptase–polymerase chain reaction. Immunostaining was also positive against
myosin heavy chain and troponin-T. In contrast, only -actin expression was
observed in the human mesenchymal stem cells incubated with conditioned media
 serum.
Conclusion: In addition to soluble signaling molecules, direct cell-to-cell contact is
obligatory in relaying the external cues of the microenvironment controlling the
differentiation of adult stem cells to cardiomyocytes. These data indicate that human
mesenchymal stem cells are plastic and can be reprogrammed into a cardiomyogenic
lineage that may be used in cell-based therapy for treating heart failure.
Cell transplantation is being explored as an alternative therapy fortreating patients with end-stage heart failure. Fetal cardiomyo-cytes,1,2 skeletal myoblasts,3-5 immortalized cell lines,6 fibro-blasts,7 smooth muscle cells,8 and hematopoietic stem cells9 havebeen transplanted into host myocardium. Although this implanta-tion was associated with improved cardiac function,10,11 evidence
for normal electromechanical coupling between the implanted cells and host cardi-
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omyocytes has been absent. All reported techniques of
cellular cardiomyoplasty (CCM) have limitations and short-
comings, and these depend primarily on the type of cell used
for transplantation. Ideally, cells for use in CCM should be
pluripotent, possess the capacity to differentiate to the de-
sired cell type under appropriate stimuli, have a limited
capacity to multiply, and should be capable of functional
integration into the host myocardium.
The adult human mesenchymal stem cell (hMSC) has
many of these characteristics, and as such may be highly
suitable for CCM. Under appropriate stimuli these stem
cells are highly plastic12 and can differentiate into special-
ized tissues such as cartilage,13 osteocytes,14 adipocytes,15
chondroblasts,16 myogenic cells,17 and cardiac cells.18 Mes-
enchymal stem cells treated with azacytidine transdifferen-
tiate into a cardiac phenotype in vitro.19 Moreover, these
stem cells can also differentiate into cardiomyocytes when
injected into normal or acutely injured myocardium. How-
ever, the signals that are crucial for cardiac-specific lineage
are not well known. To improve the clinical utility of
cell-based therapy, the signaling pathways that induce the
transformation of stem cells into cardiomyocytes need to be
identified to achieve successful engraftment.
Potential signals that direct stem cells to differentiate into
cardiomyocytes include chemical (soluble) and mechanical
(physical) factors. Stem cells differentiate into mature cells
based on the signals from the microenvironment. The objective
of our study was to determine whether the signals that are pro-
duced by mature cardiomyocytes are sufficient to induce stem
cells to differentiate into cardiomyocytes and whether both phys-
ical contact and soluble factors are required for this process.
Material and Methods
Three experimental groups of cell cultures were used to study the
effects of soluble and mechanical factors on the transformation of
stem cells into cardiomyocytes. In group I (Figure 1, A), adult
human cardiomyocytes were cultured alone. In group II (Figure 1,
B), hMSCs were cultured in media that had been conditioned by
separate cultures of cardiomyocytes (“conditioned media”). In
group III (Figure 1, A), stem cells and cardiomyocytes were
cultured together (“coculture”). In each group, cells were studied
for the expression of cardiac-specific genes.
Figure 1. A, Group I cardiomyocytes grown in the tissue culture plates. Group II conditioned media prepared from
the cardiomyocytes after 48 hours in culture. Group III coculture of hMSC with cardiomyocytes. B, Conditioned
media prepared from the soluble factors released from the cardiomyocytes, in which hMSC were subsequently
cultured.
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Human mesenchymal stem cells were obtained from a commercial
source (BioWhittaker Molecular Applications/Cambrex Inc, East
Rutherford, NJ). The cells were originally isolated from the bone
marrow of the posterior iliac crest of the pelvic bone of normal
healthy volunteers and were positive for SH2, SH3, SH4, CD29,
CD44, and CD45 and negative for CD14, CD34, and CD45 as
determined by flow cytometric analysis of surface antigens mark-
ers. These hMSCs were grown in human mesenchymal stem cell
medium containing 440 mL of basal medium, 50 mL of mesen-
chymal growth supplements (10% fetal bovine serum), 200
mmol/L of L-glutamine, 25 units of penicillin, and 25 g of
streptomycin at 37°C in a CO2 incubator. At 80% confluence the
hMSCs were split and subcultured.
Culture of Human Cardiomyocytes
Cultured human cardiomyocytes were obtained from BioWhittaker
Inc. The cardiomyocytes were grown in smooth muscle cell media
(SM2) containing 500 mL of smooth cell basal medium 0.5 mg/mL
of human epithelial growth factor (EGF), 5 mg/mL of insulin, 1
mg/mL of human fibroblast growth factor (FGF), 50 mg/mL gen-
tamicin, 50 mg/mL of amphotericin B, and 5% fetal bovine serum.
Preparation of Conditioned Media
The cardiomyocytes were cultured in T-25 cm2 flask with 5 mL of
SM2 media for 48 hours. The resulting conditioned media was
replaced with equal volume of fresh media. Subsequently, the
conditioned media was filtered with a 0.22 m filter and used to
feed cultures of hMSCs.
Fluorescent Staining of the Human Cardiomyocytes
Before cardiomyocytes were cocultured with hMSCs, cardiomyo-
cytes were labeled with green-fluorescent fluorescein diacetate
(CMFDA, CellTracker, Molecular Probes Inc, Eugene, Ore) and
sorted by fluorescent activated cell sorting (FACS). CMFDA is a
fluorescent chloromethyl derivative that freely diffuses through the
membranes of live cells. Once inside the cell, this mildly thiol-
reactive probe undergoes a glutathione S-transferase-mediated re-
action to produce a membrane-impermeant glutathione-fluorescent
dye adduct. In brief, CMFDA was mixed with prewarmed (37°C)
serum-free SM2 media to a final concentration of 10 mol/L. This
concentration of probe was determined to be optimal for staining
of cardiomyocytes using serial dilutions. The cardiomyoctes were
incubated with the probe for 45 minutes at room temperature. The
media was subsequently replaced with fresh serum-free media and
incubated for another 45 minutes to ensure complete modification
of the probe and then the cells were washed with phosphate-
buffered saline solution (PBS) to remove the excess fluorescent
label.
Coculture of Human Cardiomyocytes and hMSCs
Labeled human cardiomyocytes and hMSCs were mixed at a ratio
of 1:1 in SM2 media, plated at a density of 10,000 cells/cm2 and
incubated in a CO2 incubator at 37°C for 48 hours. At the end of
the experiment the cells were washed with PBS three times and
0.25% trypsin was added to detach the cells from the surface.
Cardiomyocytes and treated hMSCs were separated by FACS
before analysis.
Culture of hMSCs with Conditioned Media
Media conditioned by cultures of human cardiomyocytes was
filtered with a 0.22 m filter. Conditioned media (5 mL) was used
to feed hMSC cultures for 48 hours, at which time it was replaced
with fresh conditioned media. Duplicate experiments were con-
ducted in which 10% serum was added to the conditioned media
before feeding the hMSCs. At the end of the experiment the cells
were washed with PBS three times and 0.25% trypsin was added
to detach the cells from the surface.
FACS
After 48 hours of coculture, the differentiated hMSCs and the
human cardiomyocytes were trypsinized and centrifuged at 700
rpm for 5 minutes. The cell pellet was suspended in 5 mL of PBS
and the hMSCs were sorted and segregated with an 488-nm optical
filter. The hMSCs were collected and centrifuged at 500g for 10
minutes and processed.
Total RNA Extraction, Reverse Transcriptase-
Polymerase Chain Reaction
Total RNA was extracted from untreated hMSCs (negative con-
trol), differentiated hMSCs, and human cardiomyocytes (positive
control) using an RNeasy Mini isolation kit (Qiagen Inc, Alameda,
Calif). Reverse transcriptase-polymerase chain reaction (RT-PCR)
was performed to detect expression of myosin heavy chain, -ac-
tin, troponin-T, and troponin-I using specific primers and Super-
script One-Step RT-PCR (Invitrogen, Carlsbad, Calif) for cDNA
synthesis. Pre-denaturation was performed at 50°C for 30 minutes
and 94°C for 2 minutes. PCR amplification was carried out at 94°C
for 30 seconds, 60°C for 30 seconds, and 72°C for 30 seconds for
a total of 35 cycles and final extension of 1 cycle at 94°C for 7
minutes. The PCR products were size fractionated by 0.7% SeaKem
GTG agarose gel electrophoresis. The following primers were used:
Myosin heavy chain 5'-GGAGGAGGACAGGAAAAACCT-3'
(forward), 5'-CGGCTTCAAGGAAAATTGC-3' (reverse), troponin-T
5'-GGCAGCGGAAGAGGATGCTGAA-3' (forward), 5'-GAG-
GCACCAAGTTGGGCATGAACGA-3' (reverse), -actin 5'-CGC-
ACCACTGGCATTGTCAT-3' (forward), 5'-TTCTCCTTGATGT-
CACGCAC-3' (reverse), and troponin-I 5'-CCCTGCACCQGC-
CCCAATCAGA-3' (forward), 5'-CGAAGCCCAGCCCGGTCA-
ACT-3' (reverse). Similarly, RT-PCR was performed for expression
of the various connexins in the hMSC using specific primers as
follows Cx-45 5'-CTATGCAATGCGCTGGAAACAACA-3' (for-
ward), 5'-CCCTGATTTGCTACTGGCAGT -3' (reverse), Cx-40 5'
ATGCACTGTGCGCATGCAGGA-3' (forward), 5'-CAGGTGG-





The differentiated hMSCs were sorted by FACS and cytospun onto
slides. The cells were fixed with acetone/methanol 50%/50% vol/
vol for 5 minutes at room temperature and repeated twice. The
slides were air-dried overnight and bathed in 2 mL of PBS for 10
minutes. The slides were incubated with monoclonal immunoglob-
ulin G (IgG) primary antibody for 45 minutes at room temperature.
Primary antibodies were specific for -myosin heavy chain
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(MyHC) (A4.1025, 1:10 DSHB, University of Iowa), sarcomeric
myosin (MF-20, 1:100 DSHB, University of Iowa), cardiac tropo-
nin-T (CT-3 1:100 DSHB, University of Iowa), and troponin-I.
The cells were washed with PBS and then incubated with second-
ary antibody (fluorescein isothiocyanate-conjugated Affinipure
goat anti-mouse IgG) diluted 1:200 for 45 minutes at room tem-
perature. Fluorescence imaging was performed using Olympus
AX-70 microscope and Open Labs Software.
Results
When initially plated, adult human mesenchymal stem cells
appeared rounded in shape. After 24 hours of plating, the
cells were adherent, elongated, and spindle-shaped (Figure
2, a). During mitosis the cells regained a rounded appear-
ance and remained loosely attached until division was com-
plete. At this phase of the cell cycle the cells flattened and
elongated. The hMSCs were subcultured when they reach
80% confluence.
The cardiomyocytes had a rod-shaped morphology and
were arranged in a syncytial fashion as shown (Figure 2, b).
Their particular phenotype lineage was established by im-
munostaining against myosin heavy chain and troponin-T.
FACS analysis of cocultured hMSCs determined that
66% of the cells were in G1 phase. The remaining cells were
in S phase (21%) and G2 phase (13%).
In the coculture experiments, immunohistochemistry re-
vealed an absence of staining for fast myosin (MF-1) in both
cultured cardiomyocytes (Figure 3, a) and differentiating
hMSCs (Figure 3, b) and positive staining against sarco-
meric myosin (MF-20), -MyHC, CT-3, and troponin-I in
cardiomyocytes (Figure 3, c, e, g, and i, respectively) and in
transformed hMSCs (Figure 3, d, f, and h, respectively).
There was no staining against troponin-I protein at 2 days of
coculture (Figure 3, j). In addition, RT-PCR revealed the
expression of myosin heavy chain, -actin, and cardiac
troponin-T in cell-to-cell contact coculture (Figure 4). Un-
treated hMSCs and human cardiomyocytes were used as
negative and positive controls, respectively. In the condi-
tioned media experiments, -actin expression was noted in
the hMSCs exposed to cardiomyocyte-conditioned media,
both in the presence and absence of serum. There was no
expression of the -MyHC, troponin-I, or troponin-T in
hMSCs treated with the conditioned media (Table 1).
Importantly, the expression of gap-junction proteins (Cx
40, Cx-43, Cx-45, Cx-32) was identified in untreated cul-
tured hMSCs. This finding is particularly encouraging since
gap junctions are critical to establishment of cell-to-cell
electrochemical coupling (Figure 5 and Table 2).
Discussion
These studies demonstrate that adult human mesenchymal
stem cells have the potential to differentiate into cardiomy-
ocytes under the appropriate microenvironment. Under co-
culture conditions, when there was direct contact between
cardiomyocytes and hMSCs, the hMSCs begin to express
the cardiac-specific proteins myosin heavy chain, -actin,
and troponin-T. Strikingly, only -actin was expressed
when the hMSCs were cultured with conditioned media,
either in the presence or absence of serum, when there was
no physical contact between the cardiomyocytes and the
hMSCs.
Elements of the microenvironment provide the critical
signals to direct and control differentiation of human mes-
enchymal stem cells to a cardiac lineage. The potential
factors involved are numerous but may be broadly charac-
terized as either chemical (soluble) or physical (mechani-
cal). In these experiments, we demonstrated that the soluble
factors alone were not sufficient to induce differentiation of
hMSCs into cardiomyocytes and that physical contact be-
tween the cardiomyocytes and hMSCs is requisite. In addi-
tion, the cell density may be critically important since the
expression of cardiac specific proteins occurred when car-
Figure 2. a, Spindle-shaped human mesenchymal stem cells
(20), 24 hours after seeding on cell polystyrene cell culture
surface. b, Rod-shaped human cardiomyocytes forming intercel-
lular junctions with neighboring cells.
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Figure 3. a to h, Left panel shows positive controls, consisting of cardiomyocytes. Right panel shows transformed
hMSCs (10). a, No staining observed against fast myosin (MF-1) in human cardiomyocytes. b, No staining
observed against fast myosin (MF-1) in untreated hMSCs (negative control). d, Positive staining for sarcomeric
myosin (MF-20) in cocultured hMSCs. f, Positive staining for heavy chain myosin (-MyHC) in cocultured hMSCs.
h, Positive staining for troponin-T in cocultured hMSCs. j, Negative staining against troponin-I. c, e, g, i, Positive
staining in cultured cardiomyocytes for MF-20, -MyHC, troponin-T, and troponin-I, respectively.
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diomyocytes and hMSCs were cocultured at 1:1 ratio, but
were not detected at other plating ratios in preliminary work
performed in our laboratory.
During embryogenesis, stem cells differentiate to form
specialized organs and tissues. In the adult, some tissues are
able to regenerate lost or damaged cells through the differ-
entiation of progenitor cells or resident stem cells. However,
cardiomyocytes are not readily replaced with contractile
cells when they are lost as a result of myocardial infarction.
Cardiomyocytes are in a terminal phase of the cell cycle and
do not undergo cellular division. However, the hMSCs
progress through the cell cycle and are capable of cellular
division. The observation that 66% of the hMSCs were in
G1 phase of the cell cycle suggests that prolongation of this
phase could play an important role in directing hMSC
commitment. Because cardiomyocytes are incapable of di-
vision and no readily available source of replacement cells
exists, lost cells are partially replaced with scar tissue, while
neighboring cardiomyocytes hypertrophy in an effort to
restore cardiac function. There is no clear understanding
why stem cells that are capable of producing cardiomyo-
cytes in the embryo are incapable of such a task in the adult
heart. Recent evidence demonstrates that such replacement
may occur to a small degree, but that the rate may be too
slow to be functionally significant.20 The purpose of these
experiments was to try to elucidate some of the signals that
are involved in the differentiation of mesenchymal stem
cells into cardiomyocytes. Through a clear understanding of
these processes, we may be able to manipulate stem cells as
Figure 4. RT-PCR for specific hMSC transformation markers (48-hour coculture). Lane 1: 1-kb DNA ladder; lane 2:
hMSC (negative control); lane 3: conditioned media treated with hMSC in the presence of serum; lane 4 conditioned
media treated with hMSC in the absence of serum; lane 5: cell-cell contact-dependent coculture; lane 6: human
cardiomyocytes (positive control). -MHC, -actin, and CT-3 expression in cell-cell contact dependent coculture.
Expression of -actin in conditioned media  serum. GADPH is internal control. Tn-I is troponin-I expression in
cultured cardiomyocytes.
TABLE 1. Group I (cardiomyocytes alone) showed expres-
sion of -myosin heavy chain, -actin, troponin-T, and
troponin-I; Group II (hMSC exposed to conditioned media)
showed only expression of -actin; Group II (cell-cell
contact coculture) showed expression of -myosin heavy
chain, -actin, and troponin-T
-MyHHC -Actin Troponin-T Troponin-I
Group I    
Group II    
Group II    
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an ideal source of cells for cellular cardiomyoplasty or that
could be able to direct them to migrate to the myocardium
to replenish cardiomyocytes at a rate that can be clinically
useful.
Previous work has demonstrated the ability of stem cells
to undergo differentiation into cardiomyocytes, but these
studies have not examined the mechanisms of the differen-
tiation process. It is clear that the microenvironment of the
cells is an important component. If stem cells are implanted
into myocardial scar, they differentiate into a variety of
nonmyocyte cell types,21 reflecting the prevailing influence
of the myocardial microenvironment. Conversely, if stem
cells are implanted into an “optimally” permissive micro-
environment, they may selectively differentiate into cardi-
omyocytes.
Stem cells may also be used to repopulate the heart
without direct injection into the myocardium. In mice that
have undergone bone marrow transplantation and subse-
quent regional myocardial infarction, marrow-derived car-
diomyocytes and endothelial cells have been found in the
peri-infarct region.9 Host-derived cardiomyocytes have
been located in small numbers in transplanted human hearts
that have been later excised.22 These data demonstrate both
the ability of adult mesenchymal stem cells to differentiate
into cardiomyocytes under the proper conditions and also
reflect the pluripotent nature of these stem cells in that they
also can form the supporting structures of the heart. Finally,
stem cell–derived cardiomyocytes have only been located
in hearts subjected to injury, and not under normal condi-
tions. This suggests that the microenvironment of the stem
cell is critical in permitting the process differentiation and
that the stem cells are responding to some factor(s), either
chemical or mechanical, active during these periods of
stress or injury.
The processes that regulate cell differentiation are com-
plex, and the interactions between signals are largely un-
known. However, it is clear that the microenvironment of
the developing cell plays a critical role in determining its
ultimate fate. The components of the microenvironment that
influence cellular differentiation can be broadly classified as
either chemical or mechanical. The chemical signals include
cytokines, hormones, ionic gradients, and other soluble fac-
tors that are produced by either neighboring or distant cells.
The mechanical factors can be equally complex and may
include stimulation of receptors through direct contact with
neighboring cells or by the components of the extracellular
matrix, the influences of cell stretch or other forces, the
electrical environment of the cells, and perhaps even other
local signals.
Coculture and conditioned media techniques provide an
excellent model to study the signals that influence cellular
development and differentiation. Through the use of cocul-
ture techniques, stem cells are exposed to many of the
physical and chemical signals that are present within the
native myocardium, particularly the mechanical signals that
are produced through direct cell-to-cell contact between the
cardiomyocytes and hMSCs. In contrast, the experiments
that use conditioned media provide the soluble factors that
are elaborated from the cardiomyocytes without allowing
direct cell-to-cell contact, thus separating the effects of the
chemical stimuli from the physical. Although the condi-
tioned media contains cytokines and other soluble elements
that are elaborated from the cardiomyocytes during normal
growth, these are not sufficient to stimulate the stem cells to
differentiate into cardiomyocytes. In the conditioned media
experiments, the signals that are related to direct contact
Figure 5. Expression of gap junctions connexin-specific genes
(Cx-32, Cx-40, Cx-43, and Cx-45) in hMSC. Lane 1: 1-kb DNA
ladder; lane 2: hMSC expression of specific connexins; lane 3:
expression of connexin-specific genes in human cardiomyocytes
(positive control).
TABLE 2. Expression of connexin-specific genes in un-
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between the cell types are lacking. This suggests that the
cell-to-cell contact between cardiomyocytes and hMSCs in
the coculture scenario is critical in the differentiation pro-
cess.
Cell-cell interaction is a complex phenomenon, which
involves contact between cells through junctional com-
plexes including tight junctions, desmosomes, and gap junc-
tions. For this reason, it is important that the transformed
stem cells are capable of expressing the connexins that are
critical in the formation of gap junctions. The expression of
the gap junction proteins seen in the untreated hMSCs is
critical for the complete expression of cardiac phenotype
and functional integration into the host tissue. These pro-
teins may be involved in the signal transduction that occurs
between the hMSCs and cardiomyocytes during the cocul-
ture experiments. Perhaps the connexins have been arranged
into dormant channels that open with cell-to-cell contact
and aid in the transfer of intracellular signaling molecules.
Cell contact can also result in changes in cell shape due
to mechanical stretch imposed by neighboring cells. In
addition, homology of cell surface receptors and other pro-
teins involved in cell-cell adhesion between the cardiomy-
ocytes and stem cells could activate the differentiation-
associated genes and alter the genotype and phenotype. The
intracellular signal transduction pathways may be triggered
by transmembrane receptors such as epidermal growth fac-
tor or platelet-derived growth factor via autophosphoryla-
tion and by binding with ligands that regulate the transmis-
sion of mitogen-activated protein kinase signaling pathway
or activation of protein kinase C pathway via hydrolysis of
phosphoinositol.
Evaluation of the factors required to promote stem cell
differentiation is critical in refining the techniques of cellu-
lar cardiomyoplasty. Current techniques are inadequate to
produce a clinically significant increase in cardiac function
for a variety of reasons. When skeletal myoblasts or other
noncardiomyocytes are used, there is incomplete electrome-
chanical integration of the implanted cells with the native
cardiomyocytes. Although there may be a concomitant im-
provement in cardiac function, this is likely due to changes
in the diastolic properties of the ventricle. As such, maximal
benefit can only be obtained if the transplanted cells have
the capacity to differentiate into cardiomyocytes that can
fully integrate into the myocardium. Another concern with
the current techniques of CCM is the low rate of integration
of implanted cells. Only a small fraction of the implanted
stem cells remain viable in the myocardium after CCM,
limiting its therapeutic benefit.
If the signals that are involved in the transformation of
stem cells into cardiomyocytes can be understood, then the
rate of functional integration of these cells, and thus the
success of CCM, can be improved significantly. Because
these results suggest that mechanical factors are important
in the transformation process, then it is possible that stem
cells can be preprogrammed in vitro in an environment that
mimics many of these conditions before implantation. By
doing this, it may be possible to commit the stem cells to a
cardiomyocyte lineage before implantation to increase the
therapeutic yield of CCM.
Limitations of This Study
These studies were conducted using an in vitro controlled
microenvironment and observed for relatively short period
of time (48 hours). Although several myogenic markers
were expressed in the stem cells subjected to coculture,
-MyHC, -actin, and troponin-T are also expressed to
varying degrees by skeletal muscle cells. In addition, tro-
ponin-I was not seen in the treated stem cells. However, the
time frame of the study was relatively short, and it may take
upward of 7 days before troponin-I expression may be
detectable in transforming cells. Future studies will need to
look at this phenomenon for longer periods of time to see
the expression of other cardiac proteins. In addition, it is
anticipated that electromechanical integration of the hMSCs
with the cultured cardiomyocytes will also occur as a late
finding, if the cell cultures can be maintained long enough.
Cell fusion23 between the cardiomyocytes and hMSCs
remains a concern when interpreting these observations and
those of related studies of gene expression in differentiating
stem cells. The fact that troponin-I expression was absent in
cocultured hMSCs suggests that fusion is not responsible. A
related issue is the chance that separation of the cardiomy-
ocytes and hMSCs was not complete and that RT-PCR
amplified genes from the cardiomyocytes that contaminated
the hMSC cell population. If this were to have occurred,
then the RNA encoding troponin-I would have been seen in
the stem cells subjected to coculture.
Conclusion
In addition to soluble signaling molecules, direct cell-to-cell
contact is obligatory in relaying the external cues of the
microenvironment controlling the differentiation of adult
stem cells to cardiomyocytes. These data indicate that hM-
SCs are plastic and can be reprogrammed in vitro into a
cardiomyogenic lineage that may be used in cell-based
therapy for treating heart failure.
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